Daniela M. Ferreira

Best Publications

• Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

  M Voysey;Clemens Sac.;S A Madhi;L Y Weckx

  4904
  Citations

• Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

  M Voysey;S A Costa Clemens;S A Madhi;L Y Weckx

  1285
  Citations

• Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.

  Shuo Feng;Daniel J. Phillips;Thomas White;Homesh Sayal

  1140
  Citations

• Streptococcus pneumoniae: transmission, colonization and invasion

  Jeffrey N. Weiser;Daniela M. Ferreira;James C. Paton

  1106
  Citations

• Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.

  Katherine R W Emary;Tanya Golubchik;Parvinder K Aley;Cristina V Ariani

  647
  Citations

• Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.

  Xinxue Liu;Robert H Shaw;Arabella S V Stuart;Melanie Greenland

  511
  Citations

• Pneumolysin Activates the NLRP3 Inflammasome and Promotes Proinflammatory Cytokines Independently of TLR4

  Edel A. McNeela;Áine Burke;Daniel R. Neill;Cathy Baxter

  414
  Citations

• Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

  Unknown

  357
  Citations

• Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).

  Amy Flaxman;Natalie G Marchevsky;Daniel Jenkin;Jeremy Aboagye

  235
  Citations

• Controlled Human Infection and Rechallenge with Streptococcus pneumoniae Reveals the Protective Efficacy of Carriage in Healthy Adults

  Daniela M. Ferreira;Daniel R. Neill;Mathieu Bangert;Jenna F. Gritzfeld

  206
  Citations

• Inflammation induced by influenza virus impairs human innate immune control of pneumococcus

  Simon P. Jochems;Fernando Marcon;Beatriz F. Carniel;Mark Holloway

  198
  Citations

• Experimental infection of human volunteers

  Meta Roestenberg;Marie-Astrid Hoogerwerf;Daniela M Ferreira;Benjamin Mordmüller

  175
  Citations

• Characterization of Protective Mucosal and Systemic Immune Responses Elicited by Pneumococcal Surface Protein PspA and PspC Nasal Vaccines against a Respiratory Pneumococcal Challenge in Mice

  D. M. Ferreira;M. Darrieux;D. A. Silva;L. C. C. Leite

  147
  Citations

• Human alveolar macrophages predominately express combined classical M1 and M2 surface markers in steady state.

  Unknown

  141
  Citations

• Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection

  Unknown

  122
  Citations

• T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice.

  Daniel R. Neill;Vitor E. Fernandes;Laura Wisby;Andrew R. Haynes

  119
  Citations

• Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition.

  M. Darrieux;E. N. Miyaji;D. M. Ferreira;L. M. Lopes

  118
  Citations

• Experimental Human Pneumococcal Carriage Augments IL-17A-dependent T-cell Defence of the Lung

  Adam K. A. Wright;Mathieu Bangert;Jenna F. Gritzfeld;Daniela M. Ferreira

  116
  Citations

• The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease

  Luke Richards;Daniela M. Ferreira;Eliane N. Miyaji;Peter W. Andrew

  114
  Citations

• Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.

  Adriana T. Moreno;Maria Leonor S. Oliveira;Daniela M. Ferreira;Paulo L. Ho

  113
  Citations